Nucleate SD: Inside Venture Creation 101
Join us for an immersive panel on the fundamentals of biotech venture creation. We’re bringing together a panel of serial entrepreneurs, venture capitalists, and regulatory strategy experts to deconstruct the journey from ideation to exit.
Our experts will dive deep into:
Ideation: Identifying high-impact scientific opportunities.
The Framework: Navigating regulatory pathways and legal hurdles.
The Pitch: Mastering the art of storytelling to win over investors.
Fundraising: Understanding what VCs really look for in a seed-stage startup.
Whether you are a PhD candidate or an undergrad curious about the business of science, this session will provide the blueprint you need to build the next great biotech venture. Learn more about our panelists below.
Ardy Arianpour: Ardy Arianpour is CEO & Co-Founder of SEQSTER, the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in life sciences, pharma and digital health.
SEQSTER was founded in 2016 in San Diego with the mission of positively impacting patient lives at scale by removing the barriers to health data access. Prior to starting SEQSTER, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.
Sandra Pankow: Sandra is the founder and CEO of 3D BioAnalytiX. BioAnalytiX provide innovative tools to help you advance your drug development and structural proteomics research and develop better diagnostic tests to help find cures for devastating diseases faster
Chris Mason: Chris Mason is a clinician-scientist with over 30 years of cell and gene therapy experience spanning R&D clinical medicine, manufacturing, and commercialization. He is a serial entrepreneur, including a Founder and CEO of Sun Vectors, and Founder and Board Director of OriBiotech, both focused on enabling cell and gene therapy for everyone regardless of geography or financial resources. He was a Founder and former Chief Scientific Officer at Avrobio and Board Director of several companies, including Krystal Biotech and Papillon Therapeutics. Chris was instrumental in the founding of the industry advocacy group, the Alliance for Regenerative Medicine [ARM], and is a current Board Director. He is a Full Professor of Cell and Gene Therapy at University College London, and is the Senior Editor of the journals, ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’.
Michalyn Andrews
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta